img

Global and India Endothelin Antagonists Therapeutics Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and India Endothelin Antagonists Therapeutics Market Report & Forecast 2024-2034

Endothelin are the type of therapeutics that inhibits the action of endothelin and is thus effective for treating pulmonary arterial hypertension. This receptor, which plays a major role in regulating vascular tone, is found between the lumen and underlying media of the pulmonary vasculature. For patients suffering from the pulmonary hypertension, the body secrete high amount of endothelin that causes the blood vessels to be constricted and increase in the BP in the pulmonary arteries.
Market Analysis and InsightsGlobal and India Endothelin Antagonists Therapeutics Market
This report focuses on global and India Endothelin Antagonists Therapeutics market, also covers the segmentation data of other regions in regional level and county level.
The global Endothelin Antagonists Therapeutics revenue was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period (2024-2034).
In India the Endothelin Antagonists Therapeutics revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period (2024-2034).
The global key players of Endothelin Antagonists Therapeutics include Gilead Sciences, Inc, Sun Pharmaceutical Industries Ltd, Lupin, Zydus Group, Endo International plc, Mylan NV, Teva Pharmaceutical Industries Ltd, Sigmapharm Laboratories , LLC and Alembic Pharmaceuticals Limited, etc. The global five biggest players hold a share of % in 2024.
Global Endothelin Antagonists Therapeutics Scope and Market Size
Endothelin Antagonists Therapeutics market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Endothelin Antagonists Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2034.
For India market, this report focuses on the Endothelin Antagonists Therapeutics market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in India.



By Company


Gilead Sciences, Inc
Sun Pharmaceutical Industries Ltd
Lupin
Zydus Group
Endo International plc
Mylan NV
Teva Pharmaceutical Industries Ltd
Sigmapharm Laboratories , LLC
Alembic Pharmaceuticals Limited
Hikma Pharmaceuticals PLC
Amneal Pharmaceuticals LLC
AstraZeneca
Johnsons & Johnsons Private limited
GSK Plc
Segment by Type
Oral
Parenteral

Segment by Application


Cardiovascular Diseases
Scleroderma
Other
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Endothelin Antagonists Therapeutics definition, global sales (volume and revenue), India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Endothelin Antagonists Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Endothelin Antagonists Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Endothelin Antagonists Therapeutics sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Endothelin Antagonists Therapeutics Product Introduction
1.2 Global Endothelin Antagonists Therapeutics Outlook 2018 VS 2024 VS 2034
1.2.1 Global Endothelin Antagonists Therapeutics Sales in US$ Million for the Year 2018-2034
1.2.2 Global Endothelin Antagonists Therapeutics Sales in Volume for the Year 2018-2034
1.3 India Endothelin Antagonists Therapeutics Outlook 2018 VS 2024 VS 2034
1.3.1 India Endothelin Antagonists Therapeutics Sales in US$ Million for the Year 2018-2034
1.3.2 India Endothelin Antagonists Therapeutics Sales in Volume for the Year 2018-2034
1.4 Endothelin Antagonists Therapeutics Market Size, India VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of India Endothelin Antagonists Therapeutics in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Endothelin Antagonists Therapeutics Market Size, India VS Global, 2018 VS 2024 VS 2034
1.5 Endothelin Antagonists Therapeutics Market Dynamics
1.5.1 Endothelin Antagonists Therapeutics Industry Trends
1.5.2 Endothelin Antagonists Therapeutics Market Drivers
1.5.3 Endothelin Antagonists Therapeutics Market Challenges
1.5.4 Endothelin Antagonists Therapeutics Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Endothelin Antagonists Therapeutics by Type
2.1 Endothelin Antagonists Therapeutics Market Segment by Type
2.1.1 Oral
2.1.2 Parenteral
2.2 Global Endothelin Antagonists Therapeutics Market Size by Type
2.2.1 Global Endothelin Antagonists Therapeutics Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global Endothelin Antagonists Therapeutics Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global Endothelin Antagonists Therapeutics Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 India Endothelin Antagonists Therapeutics Market Size by Type
2.3.1 India Endothelin Antagonists Therapeutics Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 India Endothelin Antagonists Therapeutics Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 India Endothelin Antagonists Therapeutics Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 Endothelin Antagonists Therapeutics by Application
3.1 Endothelin Antagonists Therapeutics Market Segment by Application
3.1.1 Cardiovascular Diseases
3.1.2 Scleroderma
3.1.3 Other
3.2 Global Endothelin Antagonists Therapeutics Market Size by Application
3.2.1 Global Endothelin Antagonists Therapeutics Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global Endothelin Antagonists Therapeutics Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global Endothelin Antagonists Therapeutics Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 India Endothelin Antagonists Therapeutics Market Size by Application
3.3.1 India Endothelin Antagonists Therapeutics Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 India Endothelin Antagonists Therapeutics Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 India Endothelin Antagonists Therapeutics Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global Endothelin Antagonists Therapeutics Competitor Landscape by Company
4.1 Global Endothelin Antagonists Therapeutics Market Size by Company
4.1.1 Global Key Manufacturers of Endothelin Antagonists Therapeutics, Ranked by Revenue (2024)
4.1.2 Global Endothelin Antagonists Therapeutics Revenue by Manufacturer (2018-2023)
4.1.3 Global Endothelin Antagonists Therapeutics Sales by Manufacturer (2018-2023)
4.1.4 Global Endothelin Antagonists Therapeutics Price by Manufacturer (2018-2023)
4.2 Global Endothelin Antagonists Therapeutics Concentration Ratio (CR)
4.2.1 Endothelin Antagonists Therapeutics Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Endothelin Antagonists Therapeutics in 2024
4.2.3 Global Endothelin Antagonists Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Endothelin Antagonists Therapeutics, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Endothelin Antagonists Therapeutics, Product Offered and Application
4.5 Global Key Manufacturers of Endothelin Antagonists Therapeutics, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Endothelin Antagonists Therapeutics Market Size by Company
4.7.1 Key Players of Endothelin Antagonists Therapeutics in India, Ranked by Revenue (2024)
4.7.2 India Endothelin Antagonists Therapeutics Revenue by Players (2018-2023)
4.7.3 India Endothelin Antagonists Therapeutics Sales by Players (2018-2023)
5 Global Endothelin Antagonists Therapeutics Market Size by Region
5.1 Global Endothelin Antagonists Therapeutics Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Endothelin Antagonists Therapeutics Market Size in Volume by Region (2018-2034)
5.2.1 Global Endothelin Antagonists Therapeutics Sales in Volume by Region: 2018-2023
5.2.2 Global Endothelin Antagonists Therapeutics Sales in Volume Forecast by Region (2024-2034)
5.3 Global Endothelin Antagonists Therapeutics Market Size in Value by Region (2018-2034)
5.3.1 Global Endothelin Antagonists Therapeutics Sales in Value by Region: 2018-2023
5.3.2 Global Endothelin Antagonists Therapeutics Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Endothelin Antagonists Therapeutics Market Size YoY Growth 2018-2034
6.2 Americas Endothelin Antagonists Therapeutics Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas Endothelin Antagonists Therapeutics Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas Endothelin Antagonists Therapeutics Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Endothelin Antagonists Therapeutics Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Endothelin Antagonists Therapeutics Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Endothelin Antagonists Therapeutics Market Size YoY Growth 2018-2034
7.2 EMEA Endothelin Antagonists Therapeutics Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA Endothelin Antagonists Therapeutics Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA Endothelin Antagonists Therapeutics Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Endothelin Antagonists Therapeutics Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Endothelin Antagonists Therapeutics Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Endothelin Antagonists Therapeutics Market Size YoY Growth 2018-2034
8.2 China Endothelin Antagonists Therapeutics Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China Endothelin Antagonists Therapeutics Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC Endothelin Antagonists Therapeutics Market Size YoY Growth 2018-2034
9.2 APAC Endothelin Antagonists Therapeutics Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC Endothelin Antagonists Therapeutics Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC Endothelin Antagonists Therapeutics Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Endothelin Antagonists Therapeutics Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Endothelin Antagonists Therapeutics Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Gilead Sciences, Inc
10.1.1 Gilead Sciences, Inc Company Information
10.1.2 Gilead Sciences, Inc Description and Business Overview
10.1.3 Gilead Sciences, Inc Endothelin Antagonists Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Gilead Sciences, Inc Endothelin Antagonists Therapeutics Products Offered
10.1.5 Gilead Sciences, Inc Recent Development
10.2 Sun Pharmaceutical Industries Ltd
10.2.1 Sun Pharmaceutical Industries Ltd Company Information
10.2.2 Sun Pharmaceutical Industries Ltd Description and Business Overview
10.2.3 Sun Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sun Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Products Offered
10.2.5 Sun Pharmaceutical Industries Ltd Recent Development
10.3 Lupin
10.3.1 Lupin Company Information
10.3.2 Lupin Description and Business Overview
10.3.3 Lupin Endothelin Antagonists Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Lupin Endothelin Antagonists Therapeutics Products Offered
10.3.5 Lupin Recent Development
10.4 Zydus Group
10.4.1 Zydus Group Company Information
10.4.2 Zydus Group Description and Business Overview
10.4.3 Zydus Group Endothelin Antagonists Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Zydus Group Endothelin Antagonists Therapeutics Products Offered
10.4.5 Zydus Group Recent Development
10.5 Endo International plc
10.5.1 Endo International plc Company Information
10.5.2 Endo International plc Description and Business Overview
10.5.3 Endo International plc Endothelin Antagonists Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Endo International plc Endothelin Antagonists Therapeutics Products Offered
10.5.5 Endo International plc Recent Development
10.6 Mylan NV
10.6.1 Mylan NV Company Information
10.6.2 Mylan NV Description and Business Overview
10.6.3 Mylan NV Endothelin Antagonists Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Mylan NV Endothelin Antagonists Therapeutics Products Offered
10.6.5 Mylan NV Recent Development
10.7 Teva Pharmaceutical Industries Ltd
10.7.1 Teva Pharmaceutical Industries Ltd Company Information
10.7.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
10.7.3 Teva Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Teva Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Products Offered
10.7.5 Teva Pharmaceutical Industries Ltd Recent Development
10.8 Sigmapharm Laboratories , LLC
10.8.1 Sigmapharm Laboratories , LLC Company Information
10.8.2 Sigmapharm Laboratories , LLC Description and Business Overview
10.8.3 Sigmapharm Laboratories , LLC Endothelin Antagonists Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Sigmapharm Laboratories , LLC Endothelin Antagonists Therapeutics Products Offered
10.8.5 Sigmapharm Laboratories , LLC Recent Development
10.9 Alembic Pharmaceuticals Limited
10.9.1 Alembic Pharmaceuticals Limited Company Information
10.9.2 Alembic Pharmaceuticals Limited Description and Business Overview
10.9.3 Alembic Pharmaceuticals Limited Endothelin Antagonists Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Alembic Pharmaceuticals Limited Endothelin Antagonists Therapeutics Products Offered
10.9.5 Alembic Pharmaceuticals Limited Recent Development
10.10 Hikma Pharmaceuticals PLC
10.10.1 Hikma Pharmaceuticals PLC Company Information
10.10.2 Hikma Pharmaceuticals PLC Description and Business Overview
10.10.3 Hikma Pharmaceuticals PLC Endothelin Antagonists Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Hikma Pharmaceuticals PLC Endothelin Antagonists Therapeutics Products Offered
10.10.5 Hikma Pharmaceuticals PLC Recent Development
10.11 Amneal Pharmaceuticals LLC
10.11.1 Amneal Pharmaceuticals LLC Company Information
10.11.2 Amneal Pharmaceuticals LLC Description and Business Overview
10.11.3 Amneal Pharmaceuticals LLC Endothelin Antagonists Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Amneal Pharmaceuticals LLC Endothelin Antagonists Therapeutics Products Offered
10.11.5 Amneal Pharmaceuticals LLC Recent Development
10.12 AstraZeneca
10.12.1 AstraZeneca Company Information
10.12.2 AstraZeneca Description and Business Overview
10.12.3 AstraZeneca Endothelin Antagonists Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.12.4 AstraZeneca Endothelin Antagonists Therapeutics Products Offered
10.12.5 AstraZeneca Recent Development
10.13 Johnsons & Johnsons Private limited
10.13.1 Johnsons & Johnsons Private limited Company Information
10.13.2 Johnsons & Johnsons Private limited Description and Business Overview
10.13.3 Johnsons & Johnsons Private limited Endothelin Antagonists Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Johnsons & Johnsons Private limited Endothelin Antagonists Therapeutics Products Offered
10.13.5 Johnsons & Johnsons Private limited Recent Development
10.14 GSK Plc
10.14.1 GSK Plc Company Information
10.14.2 GSK Plc Description and Business Overview
10.14.3 GSK Plc Endothelin Antagonists Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.14.4 GSK Plc Endothelin Antagonists Therapeutics Products Offered
10.14.5 GSK Plc Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Endothelin Antagonists Therapeutics Industry Chain Analysis
11.2 Endothelin Antagonists Therapeutics Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Endothelin Antagonists Therapeutics Production Mode & Process
11.4 Endothelin Antagonists Therapeutics Sales and Marketing
11.4.1 Endothelin Antagonists Therapeutics Sales Channels
11.4.2 Endothelin Antagonists Therapeutics Distributors
11.5 Endothelin Antagonists Therapeutics Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Endothelin Antagonists Therapeutics CAGR in Value, India VS Global, 2018 VS 2024 VS 2034
Table 2. Endothelin Antagonists Therapeutics Market Trends
Table 3. Endothelin Antagonists Therapeutics Market Drivers
Table 4. Endothelin Antagonists Therapeutics Market Challenges
Table 5. Endothelin Antagonists Therapeutics Market Restraints
Table 6. Global Endothelin Antagonists Therapeutics Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. India Endothelin Antagonists Therapeutics Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Endothelin Antagonists Therapeutics Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. India Endothelin Antagonists Therapeutics Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Endothelin Antagonists Therapeutics, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Endothelin Antagonists Therapeutics Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Endothelin Antagonists Therapeutics Revenue Share by Manufacturer, 2018-2023
Table 13. Global Endothelin Antagonists Therapeutics Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Endothelin Antagonists Therapeutics Sales Share by Manufacturer, 2018-2023
Table 15. Global Endothelin Antagonists Therapeutics Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Endothelin Antagonists Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Endothelin Antagonists Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endothelin Antagonists Therapeutics as of 2024)
Table 18. Global Key Manufacturers of Endothelin Antagonists Therapeutics, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Endothelin Antagonists Therapeutics, Product Offered and Application
Table 20. Global Key Manufacturers of Endothelin Antagonists Therapeutics, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Endothelin Antagonists Therapeutics in India, Ranked by Revenue (2024) & (US$ million)
Table 23. India Endothelin Antagonists Therapeutics Revenue by Players, (US$ Million), (2018-2023)
Table 24. India Endothelin Antagonists Therapeutics Revenue Share by Players, (2018-2023)
Table 25. India Endothelin Antagonists Therapeutics Sales by Players, (K Units), (2018-2023)
Table 26. India Endothelin Antagonists Therapeutics Sales Share by Players, (2018-2023)
Table 27. Global Endothelin Antagonists Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Endothelin Antagonists Therapeutics Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Endothelin Antagonists Therapeutics Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global Endothelin Antagonists Therapeutics Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Endothelin Antagonists Therapeutics Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Endothelin Antagonists Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Endothelin Antagonists Therapeutics Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Endothelin Antagonists Therapeutics Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Endothelin Antagonists Therapeutics Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Endothelin Antagonists Therapeutics Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA Endothelin Antagonists Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Endothelin Antagonists Therapeutics Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Endothelin Antagonists Therapeutics Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Endothelin Antagonists Therapeutics Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Endothelin Antagonists Therapeutics Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC Endothelin Antagonists Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Endothelin Antagonists Therapeutics Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Endothelin Antagonists Therapeutics Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Endothelin Antagonists Therapeutics Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Endothelin Antagonists Therapeutics Sales in Volume by Country (2024-2034) & (K Units)
Table 47. Gilead Sciences, Inc Company Information
Table 48. Gilead Sciences, Inc Description and Business Overview
Table 49. Gilead Sciences, Inc Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. Gilead Sciences, Inc Endothelin Antagonists Therapeutics Product
Table 51. Gilead Sciences, Inc Recent Development
Table 52. Sun Pharmaceutical Industries Ltd Company Information
Table 53. Sun Pharmaceutical Industries Ltd Description and Business Overview
Table 54. Sun Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. Sun Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Product
Table 56. Sun Pharmaceutical Industries Ltd Recent Development
Table 57. Lupin Company Information
Table 58. Lupin Description and Business Overview
Table 59. Lupin Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. Lupin Endothelin Antagonists Therapeutics Product
Table 61. Lupin Recent Development
Table 62. Zydus Group Company Information
Table 63. Zydus Group Description and Business Overview
Table 64. Zydus Group Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. Zydus Group Endothelin Antagonists Therapeutics Product
Table 66. Zydus Group Recent Development
Table 67. Endo International plc Company Information
Table 68. Endo International plc Description and Business Overview
Table 69. Endo International plc Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. Endo International plc Endothelin Antagonists Therapeutics Product
Table 71. Endo International plc Recent Development
Table 72. Mylan NV Company Information
Table 73. Mylan NV Description and Business Overview
Table 74. Mylan NV Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. Mylan NV Endothelin Antagonists Therapeutics Product
Table 76. Mylan NV Recent Development
Table 77. Teva Pharmaceutical Industries Ltd Company Information
Table 78. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 79. Teva Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. Teva Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Product
Table 81. Teva Pharmaceutical Industries Ltd Recent Development
Table 82. Sigmapharm Laboratories , LLC Company Information
Table 83. Sigmapharm Laboratories , LLC Description and Business Overview
Table 84. Sigmapharm Laboratories , LLC Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Sigmapharm Laboratories , LLC Endothelin Antagonists Therapeutics Product
Table 86. Sigmapharm Laboratories , LLC Recent Development
Table 87. Alembic Pharmaceuticals Limited Company Information
Table 88. Alembic Pharmaceuticals Limited Description and Business Overview
Table 89. Alembic Pharmaceuticals Limited Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Alembic Pharmaceuticals Limited Endothelin Antagonists Therapeutics Product
Table 91. Alembic Pharmaceuticals Limited Recent Development
Table 92. Hikma Pharmaceuticals PLC Company Information
Table 93. Hikma Pharmaceuticals PLC Description and Business Overview
Table 94. Hikma Pharmaceuticals PLC Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Hikma Pharmaceuticals PLC Endothelin Antagonists Therapeutics Product
Table 96. Hikma Pharmaceuticals PLC Recent Development
Table 97. Amneal Pharmaceuticals LLC Company Information
Table 98. Amneal Pharmaceuticals LLC Description and Business Overview
Table 99. Amneal Pharmaceuticals LLC Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. Amneal Pharmaceuticals LLC Endothelin Antagonists Therapeutics Product
Table 101. Amneal Pharmaceuticals LLC Recent Development
Table 102. AstraZeneca Company Information
Table 103. AstraZeneca Description and Business Overview
Table 104. AstraZeneca Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. AstraZeneca Endothelin Antagonists Therapeutics Product
Table 106. AstraZeneca Recent Development
Table 107. Johnsons & Johnsons Private limited Company Information
Table 108. Johnsons & Johnsons Private limited Description and Business Overview
Table 109. Johnsons & Johnsons Private limited Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Johnsons & Johnsons Private limited Endothelin Antagonists Therapeutics Product
Table 111. Johnsons & Johnsons Private limited Recent Development
Table 112. GSK Plc Company Information
Table 113. GSK Plc Description and Business Overview
Table 114. GSK Plc Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. GSK Plc Endothelin Antagonists Therapeutics Product
Table 116. GSK Plc Recent Development
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Endothelin Antagonists Therapeutics Customers List
Table 120. Endothelin Antagonists Therapeutics Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Endothelin Antagonists Therapeutics Product Picture
Figure 2. Global Endothelin Antagonists Therapeutics Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Endothelin Antagonists Therapeutics Market Size 2018-2034 (US$ Million)
Figure 4. Global Endothelin Antagonists Therapeutics Sales 2018-2034 (K Units)
Figure 5. India Endothelin Antagonists Therapeutics Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. India Endothelin Antagonists Therapeutics Market Size 2018-2034 (US$ Million)
Figure 7. India Endothelin Antagonists Therapeutics Sales 2018-2034 (K Units)
Figure 8. India Endothelin Antagonists Therapeutics Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. India Endothelin Antagonists Therapeutics Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. Endothelin Antagonists Therapeutics Report Years Considered
Figure 11. Product Picture of Oral
Figure 12. Product Picture of Parenteral
Figure 13. Global Endothelin Antagonists Therapeutics Market Share by Type in 2024 & 2034
Figure 14. Global Endothelin Antagonists Therapeutics Sales in Value by Type (2018-2034) & (US$ Million)
Figure 15. Global Endothelin Antagonists Therapeutics Sales Market Share in Value by Type (2018-2034)
Figure 16. Global Endothelin Antagonists Therapeutics Sales by Type (2018-2034) & (K Units)
Figure 17. Global Endothelin Antagonists Therapeutics Sales Market Share in Volume by Type (2018-2034)
Figure 18. Global Endothelin Antagonists Therapeutics Price by Type (2018-2034) & (US$/Unit)
Figure 19. India Endothelin Antagonists Therapeutics Market Share by Type in 2024 & 2034
Figure 20. India Endothelin Antagonists Therapeutics Sales in Value by Type (2018-2034) & (US$ Million)
Figure 21. India Endothelin Antagonists Therapeutics Sales Market Share in Value by Type (2018-2034)
Figure 22. India Endothelin Antagonists Therapeutics Sales by Type (2018-2034) & (K Units)
Figure 23. India Endothelin Antagonists Therapeutics Sales Market Share in Volume by Type (2018-2034)
Figure 24. India Endothelin Antagonists Therapeutics Price by Type (2018-2034) & (US$/Unit)
Figure 25. Product Picture of Cardiovascular Diseases
Figure 26. Product Picture of Scleroderma
Figure 27. Product Picture of Other
Figure 28. Global Endothelin Antagonists Therapeutics Market Share by Application in 2024 & 2034
Figure 29. Global Endothelin Antagonists Therapeutics Sales in Value by Application (2018-2034) & (US$ Million)
Figure 30. Global Endothelin Antagonists Therapeutics Sales Market Share in Value by Application (2018-2034)
Figure 31. Global Endothelin Antagonists Therapeutics Sales by Application (2018-2034) & (K Units)
Figure 32. Global Endothelin Antagonists Therapeutics Sales Market Share in Volume by Application (2018-2034)
Figure 33. Global Endothelin Antagonists Therapeutics Price by Application (2018-2034) & (US$/Unit)
Figure 34. India Endothelin Antagonists Therapeutics Market Share by Application in 2024 & 2034
Figure 35. India Endothelin Antagonists Therapeutics Sales in Value by Application (2018-2034) & (US$ Million)
Figure 36. India Endothelin Antagonists Therapeutics Sales Market Share in Value by Application (2018-2034)
Figure 37. India Endothelin Antagonists Therapeutics Sales by Application (2018-2034) & (K Units)
Figure 38. India Endothelin Antagonists Therapeutics Sales Market Share in Volume by Application (2018-2034)
Figure 39. India Endothelin Antagonists Therapeutics Price by Application (2018-2034) & (US$/Unit)
Figure 40. Americas Endothelin Antagonists Therapeutics Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 41. Americas Endothelin Antagonists Therapeutics Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 42. Americas Endothelin Antagonists Therapeutics Sales by Type (2018-2034) & (K Units)
Figure 43. Americas Endothelin Antagonists Therapeutics Sales Market Share in Volume by Type (2018-2034)
Figure 44. Americas Endothelin Antagonists Therapeutics Sales by Application (2018-2034) & (K Units)
Figure 45. Americas Endothelin Antagonists Therapeutics Sales Market Share in Volume by Application (2018-2034)
Figure 46. United States Endothelin Antagonists Therapeutics Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 47. Canada Endothelin Antagonists Therapeutics Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 48. Mexico Endothelin Antagonists Therapeutics Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 49. Brazil Endothelin Antagonists Therapeutics Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 50. EMEA Endothelin Antagonists Therapeutics Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 51. EMEA Endothelin Antagonists Therapeutics Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 52. EMEA Endothelin Antagonists Therapeutics Sales by Type (2018-2034) & (K Units)
Figure 53. EMEA Endothelin Antagonists Therapeutics Sales Market Share in Volume by Type (2018-2034)
Figure 54. EMEA Endothelin Antagonists Therapeutics Sales by Application (2018-2034) & (K Units)
Figure 55. EMEA Endothelin Antagonists Therapeutics Sales Market Share in Volume by Application (2018-2034)
Figure 56. Europe Endothelin Antagonists Therapeutics Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 57. Middle East Endothelin Antagonists Therapeutics Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 58. Africa Endothelin Antagonists Therapeutics Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 59. China Endothelin Antagonists Therapeutics Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 60. China Endothelin Antagonists Therapeutics Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 61. China Endothelin Antagonists Therapeutics Sales by Type (2018-2034) & (K Units)
Figure 62. China Endothelin Antagonists Therapeutics Sales Market Share in Volume by Type (2018-2034)
Figure 63. China Endothelin Antagonists Therapeutics Sales by Application (2018-2034) & (K Units)
Figure 64. China Endothelin Antagonists Therapeutics Sales Market Share in Volume by Application (2018-2034)
Figure 65. APAC Endothelin Antagonists Therapeutics Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 66. APAC Endothelin Antagonists Therapeutics Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 67. APAC Endothelin Antagonists Therapeutics Sales by Type (2018-2034) & (K Units)
Figure 68. APAC Endothelin Antagonists Therapeutics Sales Market Share in Volume by Type (2018-2034)
Figure 69. APAC Endothelin Antagonists Therapeutics Sales by Application (2018-2034) & (K Units)
Figure 70. APAC Endothelin Antagonists Therapeutics Sales Market Share in Volume by Application (2018-2034)
Figure 71. Japan Endothelin Antagonists Therapeutics Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 72. South Korea Endothelin Antagonists Therapeutics Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 73. China Taiwan Endothelin Antagonists Therapeutics Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 74. Southeast Asia Endothelin Antagonists Therapeutics Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 75. India Endothelin Antagonists Therapeutics Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 76. Endothelin Antagonists Therapeutics Value Chain
Figure 77. Endothelin Antagonists Therapeutics Production Process
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed